首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Anti-inflammatory and anti-osteoarthritis effects of fermented Achyranthes japonica Nakai
【24h】

Anti-inflammatory and anti-osteoarthritis effects of fermented Achyranthes japonica Nakai

机译:发酵牛膝的抗炎和抗骨关节炎作用

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacological relevance: Achyranthyes japonica Nakai (AJN) has been traditionally used to control pain and improve dysfunction in osteoarthritis (OA) patients. Aim of the study: The objectives of the present study were to investigate anti-inflammatory and anti-osteoarthritis activities of fermented AJN (FAJN). Materials and methods: Anti-inflammatory activity of non-fermented AJN (NFAJN) and FAJN was evaluated by in vitro assay using LPS-induced RAW 264.7 cells. In addition, their cartilage protective effects were also determined in vitro assay using SW1353 cell and in vivo model system using collagenase-induced arthritis (CIA) in rabbits. Moreover, we isolated and identified 20-hydroxyecdysone (20-HES) as a marker component in FAJN. Result: FAJN showed stronger anti-inflammatory activity than NFAJN through inhibiting production of NO and PGE2 in LPS-induced RAW 264.7, and lowering levels of MMP-3 release in SW1353 cells treated with TNF-a. FAJN contained higher levels of 20-HES, as a marker component, than AJN. FAJN ameliorates the progress of OA by inhibiting local inflammation. It does this by regulating levels of TNF-a and IL-4, and protecting articular cartilage by preventing destruction of proteoglycan, collagens, and also preventing injury to chondrocytes. Conclusion: Therefore, FAJN is a potential therapeutic agent for reduction of cartilage damage that occurs in OA.
机译:人种药理学相关性:传统上已将Achyranthyes japonica Nakai(AJN)用于控制疼痛并改善骨关节炎(OA)患者的功能障碍。研究目的:本研究的目的是研究发酵的AJN(FAJN)的抗炎和抗骨关节炎活性。材料和方法:非体外发酵的AJN(NFAJN)和FAJN的抗炎活性通过体外试验使用LPS诱导的RAW 264.7细胞进行评估。此外,还使用SW1353细胞在体外测定中和使用胶原酶诱导的关节炎(CIA)在兔中的体内模型系统中确定了它们的软骨保护作用。此外,我们分离并鉴定了20-羟基蜕皮酮(20-HES)作为FAJN中的标志物成分。结果:FAJN通过抑制LPS诱导的RAW 264.7中NO和PGE2的产生以及降低TNF-a处理的SW1353细胞中MMP-3的释放水平,显示出比NFAJN更强的抗炎活性。 FAJN比AJN含有更高水平的20-HES作为标记物。 FAJN通过抑制局部炎症改善了OA的进展。它通过调节TNF-a和IL-4的水平来做到这一点,并通过防止蛋白聚糖,胶原蛋白的破坏以及防止软骨细胞的损伤来保护关节软骨。结论:因此,FAJN是减少OA中发生的软骨损伤的潜在治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号